CompaniesInvestorsPeople
Home
Loading

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

Get in Touch

  • Contact

  • Request a Demo

  • Request Data Updates

  • Add a Company

Research

  • Companies

  • Investors

  • People

aVenture

  • Download App

  • Pricing

Download the aVenture Research beta for iOS and iPadOSDownload aVenture Research on the Mac App Store

Resources

  • Documentation

  • Use Cases

  • CLI

  • MCP

  • Feature Requests

  • Sitemap

Member

Backed by

Ask AI about aVenture

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy · Terms of Service

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading
Home›
Companies›
Cara Therapeutics›
Fundraising
Cara Therapeutics logo

Cara Therapeutics

Cara Therapeutics, a Connecticut-based medical firm, develops novel drugs for pain and inflammation treatment.

Stamford, CT, US🇺🇸
Founded
2004
Loading
Overview
Compare
Fundraising
Employees
Library

Cara Therapeutics - Funding History

Round

Date

Amount Raised

Raised To-Date

Investors

Post IPO
November 2023
$40,000,000
-
1
Post IPO Equity
July 2019
$145,500,000
-
0
Post IPO Equity
July 2018
$98,300,000
-
0
Post IPO Equity
March 2017
$92,100,000
-
0
Post IPO Equity
July 2015
$80,500,000
-
0
IPO
January 2014
-
-
0
Series D
May 2012
$4,800,000
-
7
Series D
July 2010
$15,000,000
-
8
Series C
July 2008
$12,300,000
-
4
Series C
November 2006
$24,000,000
-
5

Cara Therapeutics - Investors

Cara Therapeutics has raised money from at least 13 different investors as of October 15, 2026

Name

Location

Links

Type

Employees

Round(s)

HealthCare Royalty PartnersHealthCare Royalty Partners
Stamford, CT, US
LinkedIn
Investment Firm
34
Post IPO
Ascent Biomedical VenturesAscent Biomedical Ventures
New York City, NY, US
LinkedIn
Investment Firm
31
Series BSeries C
Mitsubishi MotorsMitsubishi Motors
Tokyo, JP
LinkedIn
Company
42,625
Series D
Devon Park BioventuresDevon Park Bioventures
Wayne, PA, US
LinkedIn
Investment Firm
7
Series CSeries D
Rho VenturesRho Ventures
New York City, NY, US
LinkedIn
Investment Firm
40
Series D
Alta PartnersAlta Partners
Jackson, MS, US
LinkedIn
Investment Firm
18
Series CSeries D
CT InnovationCT Innovation
Verona, Province of Verona, IT
LinkedIn
Company
8
Series D
MVM PartnersMVM Partners
London, Greater London, GB
LinkedIn
Investment Firm
35
Series CSeries D
Scottish Widows Investment PartnershipScottish Widows Investment Partnership
Edinburgh, City of Edinburgh, GB
LinkedIn
Investment Firm
0
Series CSeries D
MitsubishiMitsubishi
Tokyo, JP
LinkedIn
Company
79,706
Series D